SMCI Launches Metabolomics Study

Cort

Founder of Health Rising and Phoenix Rising
Staff member
I've never seen an area of research expand so fast. The SMCI is launching what appears to be a quite comprehensive metabolomics study with Maureen Hanson and Dr. Levine. These multiple studies - coming from Naviaux, Ron Davis/OMF, Lipkin, McGregor/Armstrong, Fluge/Mella and now SMCI and Hanson - are exactly what we've needed and in general haven't gotten in other areas.

Because we now have multiple studies, if they find common signatures the findings can be validated quickly. If the core findings are validated then the next step - which has already started with Naviaux - is comparing them to other diseases in order to find a biomarker or biomarkers. The Aussies have begun longitudinal studies over time which include genetic testing and treatments.

Metabolon is the company Ron Davis and the Open Medicine Foundation are using to assess metabolomics in their severe patient stuy. They are also working with Metabolon produce a metabolomics test kit for ME/CFS. The OMF is also funding Bob Naviuax's research in his own lab.

Given how many researchers we know of its possible that others that we don't know of have begun doing metabolomics testing.

New Research Project Launches through SMCI’s Targeted Initiative Research Program

Friday, October 14, 2016
SMCI recently launched a new partnership as a component of our targeted initiative program, within our Pathways and Biomarkers Discovery Track. The project consists of original research in the areas of bioenergetics, metabolomics, and lipidomics using high-throughput technology. Importantly, this new SMCI research project relies on blood from well-qualified patients from The Levine Clinic; it also builds on recent discoveries in gut microbiome from Dr. Maureen Hanson’s lab, which uses these same patients.
As always, we partner with experts. In this instance, we have brought together the following group: Dr. Hanson, a professor of molecular biology and genetics at Cornell University; Dr. Levine, a member of SMCI’s Research Advisory Council and the chair of the Department of Health and Human Services Chronic Fatigue Syndrome Advisory Committee; and Metabolon, an industry leader in the discovery of biomarkers through the use of metabolomics (a “high-throughput technology” and a powerful scientific approach for the discovery and development of drugs and for early disease diagnosis).

Results from this new study have the potential to be quite significant and may include
  • Expanding the gut microbiome findings and providing additional context and clarity
  • Identifying specific biological signatures from well-characterized patients
  • Developing mechanistic insight into comorbidities associated with ME/CFS
  • Uncovering potential new biomarkers that could help with rapid and effective diagnosis
  • Comprehending signaling pathway interactions involved in the disease
  • Supporting existing projects and hypotheses by us and others as well as generating new hypotheses
  • Classifying patients based on molecular alterations
  • Developing precision medicine profiles, categories, and subcategories in ME/CFS with additional patients
We expect that the initial phase of this new project will be completed in the next quarter, with results requiring additional mechanistic investigation to establish findings as reproducible and validated targets.

Dr. Zaher Nahle, SMCI’s vice president for research and scientific programs, stated, “We could not be more excited about our partnership with Dr. Hanson, Dr. Levine, and Metabolon. We look forward to analyzing the metabolome of both early- and late-stage ME/CFS patients and their controls using Metabolon’s multiplex platforms.

It is our hope that this study will reveal signatures and identifiers pointing toward biomarkers as well as a molecular basis for the disease and its subgroups. The results from this study will help us to hone or validate our hypotheses. And, what’s more, we will be able to seek new partnerships and assist the work of others by publishing these results alongside our collaborators.”
 
Last edited:

Get Our Free ME/CFS and FM Blog!



Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Latest Resources

Top